No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzamides
-
DNA Mutational Analysis
-
Dose-Response Relationship, Drug
-
Genes, abl / genetics
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Imatinib Mesylate
-
Interferon-alpha / adverse effects
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Neoplasm, Residual / drug therapy
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Prognosis
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use
-
Randomized Controlled Trials as Topic
-
Remission Induction
Substances
-
Antineoplastic Agents
-
Benzamides
-
Interferon-alpha
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases